Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis’ Gilenya reduces brain shrinkage matters for people with MS
Patients who had the highest rates of brain shrinkage at two years had a higher risk of disability progression at four years
Schizophrenia has group of eight genetically distinct disorders
Study could be a first step towards improved diagnosis and treatment for the debilitating psychiatric illness
Re-Building Indian Pharma Inc
PM Modi's 'Make in India' campaign highlights pharma as one of the key sectors for growth but it is essential to first rebuild…
‘IRHT would focus on Africa, Japan and Latin America as potential markets of the future’
India Brand Equity Foundation has been at the forefront of positioning Brand India Pharma and has taken up the mantle to further…
Playing the frenemy card
AIDAN’s PIL accusing the DoP of 'browbeating' the NPPA might not be so far-fetched as innovators and generic companies cosy up…
Ajit Singh Pioneer of Pharma Packaging
With Ajit Singh at the helf of ACG Worldwide as its Chairman, the company has dominated the Indian pharmaceutical packaging…
DNA-based diagnostics present tremendous opportunities for us to invest
VC firms are integral to a thriving ecosystem, for both entrepreneurship and new start-ups in new emerging areas of the future.…
GoI, pharma industry jointly form India – Responsible Healthcare Trust
To give more thrust to the Brand India Pharma campaign
Venus forays into Singapore’s topical pain management market
Gets marketing authorisation and patent for its pain reliever Trois
Ranbaxy launches ABSORICA in the US
Ranbaxy Laboratories has launched ABSORICA (isotretinoin) 25 mg and 35 mg capsules into the US healthcare market